Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05750901 · ClinicalTrials.gov registry record · NA
Evaluation of Fractional Ablative Laser Treatment for Skin Conditions
A NA study of Skin Laxity, sponsored by Sciton.
- Recruiting
- Registry status
- NA
- Development phase
- 1,000
- Enrollment target
- 1
- Study location
NCT05750901: Recruiting NA study of Skin Laxity, sponsored by Sciton.
NCT05750901 is a NA study of Skin Laxity that is actively recruiting participants, run by Sciton. The registered enrollment target is 1,000 participants, above the 91-participant average among 10 other Skin Laxity trials with a reported enrollment target (999% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05750901, a NA study of Skin Laxity, is actively recruiting participants, sponsored by Sciton.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Evaluate the safety and efficacy of the fractional ablative laser for treatment of skin laxity and tightening
Primary Outcome
Percent improvement in wrinkles will be assessed using digital camera at baseline and post final treatment.
Conditions Studied
Interventions
- DEVICE Fractional ablative laser
Study Locations (1)
Florida
- Sanctuary Plastic Surgery - Boca Raton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2022-11-01 |
| Est. Completion | 2026-06-20 |
| Phase | NA |
What NCT05750901 shows while recruiting
NCT05750901 is an interventional study that assigns participants to a tested intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 91-participant average among 10 other Skin Laxity trials with a reported enrollment target (999% higher).
The record links to 1 condition, with Skin Laxity appearing as the primary indexed condition, and to 1 intervention - of which Fractional ablative laser is the first listed.
NCT05750901 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05750901 about?
NCT05750901 is a clinical study titled "Evaluation of Fractional Ablative Laser Treatment for Skin Conditions". Evaluate the safety and efficacy of the fractional ablative laser for treatment of skin laxity and tightening
What is the current status of trial NCT05750901?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2022-11-01. Estimated completion is 2026-06-20.
What conditions does trial NCT05750901 study?
This clinical trial studies the following conditions: Skin Laxity.
What interventions are being tested in trial NCT05750901?
The interventions under investigation include: Fractional ablative laser (DEVICE).
Who is sponsoring clinical trial NCT05750901?
This trial is sponsored by Sciton, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05750901 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Laxity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05750901's enrollment target sits among peer trials
1,000 1st of 10 higher than 10 of 10 other Skin Laxity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Skin Laxity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Characterize Human Skin Changes From Biostimulator Treatments Via Non-invasive Imaging
RECRUITING · NA
-
An Evaluation of the Erchonia Laser As a Non-Invasive Treatment to Improve the Appearance of Skin Laxity
RECRUITING · NA
-
AV-23-001 AVAVA MIRIA Pilot Study
ACTIVE NOT RECRUITING · NA
-
Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System
ACTIVE NOT RECRUITING · NA
-
Evaluation of the Effects of a Biostimulator and Dermal Fillers for Cheek Augmentation and Contour Deficiencies
ACTIVE NOT RECRUITING · NA
-
Feasibility Study: Heavy Water Tissue Labeling Protocol
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI